홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
APGE
#1241
Apogee Therapeutics, Inc. Common Stock
70.000
0
+1.13%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
+1.13%
월간 변동
-3.86%
6달 변화
+30.62%
년간 변동율
+30.62%
이전 종가
69.215
0
Open
70.000
0
Bid
Ask
Low
70.000
0
High
70.000
0
양
87
마켓
주식
헬스케어
APGE
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
45.03 M
46.02 M
46.05 M
46.11 M
68.32 M
—
Valuation ratios
Enterprise value
5.38 B
4.64 B
3.84 B
4.47 B
5.86 B
18.8 B
Price to earnings ratio
43.84
-13.73
-10.35
-10.49
-9.05
-43.62
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
19.02
14.6
11.23
11.22
9.82
46.87
Price to book ratio
0.66
1.88
0.42
0.46
0.4
3.15
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.06
0.09
0.08
0.1
0.1
0.37
Return on equity %
0.04
0.05
0.04
0.04
0.04
0.18
Return on invested capital %
—
128.54
118.85
170.82
241.58
659.79
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
16.39
18.55
15.82
16.36
15.86
66.59
Inventory turnover
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.75
1.23
0.83
1.06
0.92
4.05
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
9.26
9.43
8.82
8.65
8.97
35.88
Net current asset value per share
9.41
9.6
8.96
8.83
9.19
36.58
Tangible book value per share
21.34
24.07
23.99
25.23
26.73
100.02
Working capital per share
8.84
9.08
8.4
8.29
8.61
34.38
Book value per share
21.34
24.07
23.99
25.23
26.73
100.02
뉴스
Jefferies lowers Apogee Therapeutics stock price target on OX40 concerns
Intel, Iris Energy among market cap stock movers on Friday
Intel and AMD among market cap stock movers on Friday
Thursday’s Insider Activity: GameStop CEO’s $21M Buy Stands Out
Apogee Therapeutics stock downgraded by RBC Capital on valuation concerns
Top US Biopharma Stocks Poised for Growth in 2026, According to Deutsche Bank
Apogee Therapeutics CEO Henderson sells $1.6m in stock
Apogee Therapeutics stock hits all-time high at 81.0 USD
Regeneron announcements validate Apogee thesis, says Stifel
Apogee Therapeutics CMO sells $1.45 million in shares
Craig-Hallum raises Apogee Therapeutics stock price target on promising asthma data
UBS initiates Apogee Therapeutics stock with Buy rating, $100 target